A Phase I Study to Evaluate the Effect of Repeated Oral Doses of Delafloxacin on the Pharmacokinetics of a Single Oral Dose of Midazolam in Healthy Subjects

Trial Profile

A Phase I Study to Evaluate the Effect of Repeated Oral Doses of Delafloxacin on the Pharmacokinetics of a Single Oral Dose of Midazolam in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 May 2017

At a glance

  • Drugs Delafloxacin (Primary) ; Midazolam (Primary)
  • Indications Community-acquired pneumonia; Intra-abdominal infections; Nosocomial pneumonia; Skin and soft tissue infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Sponsors Melinta Therapeutics
  • Most Recent Events

    • 08 May 2017 Results published in the Clinical Therapeutics
    • 14 Jun 2016 Data will be presented at the ASM Microbe 2016, according to a Melinta Therapeutics media release.
    • 01 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top